Advertisement
U.S. markets close in 5 hours 17 minutes

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
2.8600-0.0400 (-1.38%)
As of 10:05AM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Upgrade to begin using 40 years of financial statements and get so much more.
 
As of Date: 3/28/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
22.86M25.17M26.19M26.54M27.09M30.24M
Enterprise Value
-12.63M-17.26M-24.32M-31.03M-40.04M-43.11M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
11.2015.0416.5813.0918.2024.53
Price/Book (mrq)
0.840.710.600.510.450.44
Enterprise Value/Revenue
-6.16-20.89-3.47k-25.47-57.94-84.21
Enterprise Value/EBITDA
0.351.732.731.764.994.90

Trading Information

Stock Price History

Beta (5Y Monthly) 0.36
52-Week Change 3-15.82%
S&P500 52-Week Change 329.57%
52 Week High 34.5500
52 Week Low 32.5100
50-Day Moving Average 32.9480
200-Day Moving Average 33.2143

Share Statistics

Avg Vol (3 month) 323.28k
Avg Vol (10 day) 320.74k
Shares Outstanding 58.11M
Implied Shares Outstanding 68.11M
Float 85.31M
% Held by Insiders 134.54%
% Held by Institutions 129.38%
Shares Short (Mar 15, 2024) 4293.57k
Short Ratio (Mar 15, 2024) 410.19
Short % of Float (Mar 15, 2024) 45.13%
Short % of Shares Outstanding (Mar 15, 2024) 43.62%
Shares Short (prior month Feb 15, 2024) 4297.21k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 19, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,211.14%

Management Effectiveness

Return on Assets (ttm)-40.53%
Return on Equity (ttm)-78.34%

Income Statement

Revenue (ttm)2.05M
Revenue Per Share (ttm)0.25
Quarterly Revenue Growth (yoy)61.30%
Gross Profit (ttm)N/A
EBITDA -36.57M
Net Income Avi to Common (ttm)-34.03M
Diluted EPS (ttm)-4.1800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)36.08M
Total Cash Per Share (mrq)4.45
Total Debt (mrq)585k
Total Debt/Equity (mrq)2.14%
Current Ratio (mrq)5.70
Book Value Per Share (mrq)3.37

Cash Flow Statement

Operating Cash Flow (ttm)-31.09M
Levered Free Cash Flow (ttm)-19.55M